Inimex Pharmaceuticals
closed Launch date
Employees
Market cap
-
Enterprise valuation
€80—120m (Dealroom.co estimates Jun 2008.)
Burnaby British Columbia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | $4.5m | Series A | |
$2.0m | Series A | ||
$6.8m | Series A | ||
$22.0m | Series B | ||
$240k | Grant | ||
Total Funding | €32.3m |
Related Content
Recent News about Inimex Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.